Ensuring that clinical investigations work in practice

Dr Paul Hercock
clinical investigator for pmcf eu mdr compliance

Well-designed clinical investigations are at the core of meeting medical device regulatory requirements under the EU MDR. More than ever before, the EU MDR requires manufacturers to have a detailed understanding of how to produce high-quality clinical evidence to support their products.

Despite this, access to medical expertise remains limited across the medical device industry. This is unfortunate not only because medical experts have so much to contribute to the structural design of clinical studies. It is also a problem because medical professionals are better placed than anyone to understand how a clinical investigation would function in practice.

Great clinical investigations combine two crucial elements:

  • a robust design that ensures the production of quality data that is free from bias and adequately addresses the hypothesis
  • an ability to be seamlessly implemented in practice

Much has been said about robust study design with perhaps too little focus on how effectively investigations can be implemented in practice. A theoretically sound study design means nothing if clinical investigators are unable or unwilling to engage with it. Incomplete investigator compliance with data entry requirements will almost certainly lead to problematic gaps in data collection that compromise the integrity of the entire investigation. It also leads to missed deadlines as patient recruitment falls behind, with an associated increase in study costs.

Neglected

When modern medical device design focuses so strongly on human factors and ethnographic research that examine how effectively a device meets the demands of its users, why isn’t the same approach taken with clinical trials?

Being a clinical investigator is not easy. Investigators are often busy clinicians who are managing multiple competing priorities. It is the job of the investigation design team to take measures to aid investigators in entering data and working with the trial.

Methods that can facilitate investigator compliance include:

  • Minimising datapoints. Collect only the information that is absolutely necessary to address the study hypothesis and/or objectives
  • Use an electronic CRF. Using a digital rather than paper-based data entry process means that data can be entered from anywhere (including smartphone and tablet), reducing disruption to investigator workflow.
  • Have a fair remuneration structure. While always ensuring that the principles of healthcare compliance are adhered to, fairly remunerating investigators for time and effort expended while working on the trial is an effective way to encourage engagement.
  • Integrate the trial into standard care. Levels of investigator compliance are likely to be far higher if engagement with the trial causes no, or minimal, disruption to standard clinical activities.

Solution

Good clinical investigation design requires a combination of scientific and medical expertise. Working with healthcare professionals who have direct experience as clinical investigators is the best way to ensure that your trials are optimally designed for maximum investigator engagement.

Mantra Systems has a team of expertly-trained medical professionals who are specialists at designing clinical investigations for PMCF and MDR compliance strategies. Whether working to demonstrate conformity to Annex I General Safety and Performance Requirements, updating PMCF systems to MDR standards or seeking to streamline your evidence portfolio, talk with a member of our team to discuss your needs.

Related articles

  1. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  2. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  3. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  4. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  5. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  6. EU regulators may delay MDR enforcement

    EU regulators may delay MDR enforcement. Out of the woods?

    A delay of the MDR would be welcome news for many, but what would a delay mean in practice? To what extent can preparations for EU MDR be put on ice?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  7. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  8. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need help with your regulatory strategy?

Talk to us